Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: J.P who wrote (752)	3/13/1998 10:20:00 PM
From: murray	Read Replies (1) of 14101

In response to your questions. There are probably two reasons I can think of for its price under 4.00. 1) the good news you hear are only increments towards the final approval of pennsaid, which will cause a significant breakout in price.But the real clincher are the multiple press releases with respect to W10F with its efficacy and low toxicity.It has been shown to be a very effective immune modulator,not only for AIDS, but perhaps a number immune-related diseases--ranging from cancer to lupus. THis could eventually make this company worth $80-100, comparing it to the price level of Biochem and its success with 3TC. 2) The biotech sector has been out of favor for awhile as investors have been chasing other sectors such as banks. When they have fully valued, they will come back to the biotech sector. We may even see a greater bull than the bull of 91-92. Companies are much more mature, many bios are getting final approval and ready to market their long awaited product. Then prices will surge. Hope these long-winded answers help. Cheers!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next